These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. Rapoport N; Nam KH; Gupta R; Gao Z; Mohan P; Payne A; Todd N; Liu X; Kim T; Shea J; Scaife C; Parker DL; Jeong EK; Kennedy AM J Control Release; 2011 Jul; 153(1):4-15. PubMed ID: 21277919 [TBL] [Abstract][Full Text] [Related]
4. Oxygent as a top load to colloid and hyperoxia is more effective in resuscitation from hemorrhagic shock than colloid and hyperoxia alone. Kemming GI; Meisner FG; Wojtczyk CJ; Packert KB; Minor T; Thiel M; Tillmanns J; Meier J; Bottino D; Keipert PE; Faithfull S; Habler OP Shock; 2005 Sep; 24(3):245-54. PubMed ID: 16135964 [TBL] [Abstract][Full Text] [Related]
5. In vitro parameter optimization for spatial control of focused ultrasound ablation when using low boiling point phase-change nanoemulsions. Puett C; Phillips LC; Sheeran PS; Dayton PA J Ther Ultrasound; 2013; 1():16. PubMed ID: 25512861 [TBL] [Abstract][Full Text] [Related]
6. Functional ultrasound-triggered phase-shift perfluorocarbon nanodroplets for cancer therapy. Guo R; Xu N; Liu Y; Ling G; Yu J; Zhang P Ultrasound Med Biol; 2021 Aug; 47(8):2064-2079. PubMed ID: 33992473 [TBL] [Abstract][Full Text] [Related]
8. Multiple Linear Regression Predictive Modeling of Colloidal and Fluorescence Stability of Theranostic Perfluorocarbon Nanoemulsions. Herneisey M; Janjic JM Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111589 [TBL] [Abstract][Full Text] [Related]
9. Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer. Rapoport N Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(5):492-510. PubMed ID: 22730185 [TBL] [Abstract][Full Text] [Related]
10. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography. Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894 [TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Perfluorocarbon-Based Delivery Systems for Cancer Theranostics. Yang Y; Liu Y; Jiang Y Mol Pharm; 2023 Jul; 20(7):3254-3277. PubMed ID: 37318162 [TBL] [Abstract][Full Text] [Related]
12. Overview of progress in the fluorocarbon approach to in vivo oxygen delivery. Riess JG Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):183-202. PubMed ID: 1391434 [TBL] [Abstract][Full Text] [Related]
13. An in vitro study of a phase-shift nanoemulsion: a potential nucleation agent for bubble-enhanced HIFU tumor ablation. Zhang P; Porter T Ultrasound Med Biol; 2010 Nov; 36(11):1856-66. PubMed ID: 20888685 [TBL] [Abstract][Full Text] [Related]
18. Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field. A contribution. Krafft MP; Riess JG Biochimie; 1998; 80(5-6):489-514. PubMed ID: 9782389 [TBL] [Abstract][Full Text] [Related]